Sialorrhea is a common and often debilitating, socially isolating and embarrassing symptom for patients with Parkinson disease (PD). The treatment of sialorrhea involves the management of saliva ...

Pharma Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurolo Jul 29, 2010 9:01am Pharma ...

You wake up from a deep sleep to find your pillow wet or your cheek slick with saliva. Drooling in your sleep can be inconvenient and embarrassing, especially if you're sleeping next to someone ...

Clozapine remains the antipsychotic agent of choice for treatment-resistant schizophrenia; however, its efficacy is frequently hampered by adverse effects such as hypersalivation and sialorrhea.

Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid ...